# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-26-010879
Filing Date
2026-04-01
Accepted
2026-04-01 16:06:00
Documents
25
Period of Report
2026-05-20

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM DEF 14A | dmtp20260331_def14a.htm iXBRL | DEF 14A | 1091907
6 |  | c2.jpg | GRAPHIC | 101480
7 |  | chart.jpg | GRAPHIC | 91301
8 |  | diamedicalogo.jpg | GRAPHIC | 6910
9 |  | dmtp20260331_def14aimg002.jpg | GRAPHIC | 2051
10 |  | kellensig.jpg | GRAPHIC | 6571
11 |  | proxy1.jpg | GRAPHIC | 260035
12 |  | proxy2.jpg | GRAPHIC | 341586
13 |  | pvp.jpg | GRAPHIC | 81060
14 |  | sig2.jpg | GRAPHIC | 5225
| Complete submission text file | 0001437749-26-010879.txt |  | 4095213

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA | dmac-20251231.xsd | EX-101.SCH | 4764
3 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | dmac-20251231_def.xml | EX-101.DEF | 2076
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | dmac-20251231_lab.xml | EX-101.LAB | 2459
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | dmac-20251231_pre.xml | EX-101.PRE | 1574
28 | EXTRACTED XBRL INSTANCE DOCUMENT | dmtp20260331_def14a_htm.xml | XML | 89189

Mailing Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305
Business Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36291 | Film No.: 26828147
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)